本页面由Tiger Trade Technology Pte. Ltd.提供服务

Trinity Biotech plc

0.7000
+0.00680.98%
盘后0.6967-0.0033-0.47%16:39 EST
成交量:3.56万
成交额:2.51万
市值:1,304.24万
市盈率:-0.47
高:0.7202
开:0.7001
低:0.6932
收:0.6932
52周最高:3.44
52周最低:0.4800
股本:1,863.20万
流通股本:1,625.41万
量比:0.18
换手率:0.22%
股息:- -
股息率:- -
每股收益(TTM):-1.4937
每股收益(LYR):-1.8319
净资产收益率:-1913.45%
总资产收益率:-9.46%
市净率:-0.24
市盈率(LYR):-0.38

数据加载中...

2026/02/25

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2026/01/22

SEC问询函

Form CORRESP - Correspondence
2026/01/15

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/05/16

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/26

SEC问询函

Form CORRESP - Correspondence
2024/11/29

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/12

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/06/27

SEC问询函

Form CORRESP - Correspondence
2024/05/03

SEC问询函

Form CORRESP - Correspondence
2024/05/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/09

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/17

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/09/12

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/25

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]